3rd Quarter - Report

INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH for INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Firm
Client
Income
—
Expenses
$30,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

HR 7188 / S 3733, Shandra Eisenga Human Cell and Tissue Products Safety Act HR 4758 / S 2372, Accelerating Kids Access to Care Act

LobbyistCovered position, as disclosed
TYLER LAMB —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 7188 (118th), H.R. 4758 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.